unknown
Stage
1
Investors
About
Foresight Diagnostics develops ultra-sensitive cancer diagnostic tests using precision genomics and bioinformatics to detect minimal residual disease and advance cancer drug development and patient care.
Explore Foresight Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.